ACI-15916

N/A

Report date: 2024/11/20 16:59:32

Base Information

Drug NameACI-15916
Drug Alias NameACI-15916[18F]ACI-15916[3H]-ACI-15916
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent
Mechanisms of ActionSynuclein alpha inhibitorsPositron-emission tomography enhancers
TargetsSynuclein alpha
Therapy Area/IndicationsSynucleinopathiesParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune Sa
Inactive CompaniesN/A
Active IndicationsSynucleinopathiesParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A